RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Ovarian Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Dec 2010 - 55 pages - $2,000
Epidemiology: Ovarian Cancer - Aging populations will drive the increase in incident cases of ovarian cancer
Dec 2010 - 24 pages - $5,700
Ovarian Cancer - Pipeline Review, Q3 2011
Jul 2011 - 324 pages - $500
Ovarian Cancer Global Clinical Trials Review, Q4, 2010
Nov 2010 - 70 pages - $1,000
AGO Ovarian Cancer Study Group – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 49 pages - $500
AGO Ovarian Cancer Study Group – Developmental Therapeutics Review – Q1 2011
Mar 2011 - 48 pages - $500
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
Stakeholder Opinions: Ovarian Cancer - Approaching the era of molecular targeted therapy
Jul 2010 - 93 pages - $3,800
Clinical Trial Endpoints in Oncology - Inclusion of Surrogate Endpoints and Shorter Endpoints Will Ensure Faster Clinical Trials in Oncology
Mar 2011 - 120 pages - $3,500
Ovarian Cancer Therapy Area Pipeline Report
Nov 2010 - 644 pages - $1,495
More Related Market Research Reports >>>

Your selection

Industry sector
Pharmaceutical del
Prescription del
Therapeutic target
Oncology del
Ovarian cancer del
Year
2006 del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us